Associated Papers
Relevance of selected pharmacogenetic polymorphisms to bleeding and thromboembolic risks in Chinese patients taking direct-acting oral anticoagulants.
Wang D et al.
British Journal of Clinical Pharmacology, 2025
Effect of donor GSTM3 rs7483 genetic variant on tacrolimus elimination in the early period after liver transplantation.
Zhang T et al.
Peerj, 2024
Characterization of 15 CYP2J2 variants identified in the Chinese Han population on the metabolism of ebastine and terfenadine in vitro.
Zou LL et al.
Frontiers in Pharmacology, 2023
Effect of ABCB1 gene variants on rivaroxaban pharmacokinetic and hemorrhage events occurring in patients with non-valvular atrial fibrillation.
Zhang D et al.
Biopharmaceutics & Drug Disposition, 2022
Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients.
Campos-Staffico AM et al.
Frontiers in Pharmacology, 2022
Comprehensive analysis of important pharmacogenes in Koreans using the DMET™ platform.
Kim B et al.
Translational and Clinical Pharmacology, 2021
Associations between CYP2J2 (-76G>T) rs890293 polymorphism and age-related macular degeneration.
Liutkeviciene R et al.
Biomedical Papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2020
CYP3A5*3 and CYP2C8*3 variants influence exposure and clinical outcomes of tacrolimus-based therapy.
Genvigir FDV et al.
Pharmacogenomics, 2020
Activity and mRNA expression levels of selected cytochromes P450 in various sections of the human small intestine.
Clermont V et al.
British Journal of Clinical Pharmacology, 2019
A comprehensive study revealed SNP-SNP interactions and a sex-dependent relationship between polymorphisms of the CYP2J2 gene and hypertension risk.
Polonikov AV et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension, 2019
Genetic polymorphisms of CYP2S1, CYP2J2 and CYP2R1 genes in three Chinese populations: Han, Tibetan and Uighur.
Kang X et al.
Pharmacogenomics, 2018
Pharmacokinetics, Pharmacodynamics and Pharmacogenetics of Tacrolimus in Kidney Transplantation.
Yu M et al.
Current Drug Metabolism, 2018
Meta-analysis of the association of the CYP2J2 G-50T polymorphism with coronary artery disease.
Chen J et al.
Oncotarget, 2017
Influence of ABCC2, CYP2C8, and CYP2J2 Polymorphisms on Tacrolimus and Mycophenolate Sodium-Based Treatment in Brazilian Kidney Transplant Recipients.
Genvigir FDV et al.
Pharmacotherapy, 2017
The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population.
Polonikov A et al.
Clinical and Experimental Hypertension (new York, N.y. : 1993), 2017
Rivaroxaban-Induced Hemorrhage Associated with ABCB1 Genetic Defect.
Ing Lorenzini K et al.
Frontiers in Pharmacology, 2016
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation.
Zanger UM et al.
Pharmacology & Therapeutics, 2013
Polymorphisms of cytochrome p450 genes in three ethnic groups from Russia.
Korytina G et al.
Balkan Medical Journal, 2012
[Polymorphic markers of the CYP1B1 (4326C > G), CYP2F1 (c.14_15insC), CYP2J2 (-76G > T), and CYP2S1 (13106C > T and 13255A > G) genes and genetic predisposition to chronic respiratory diseases induced by smoking and occupational factors].
Akhmadishina LA et al.
Genetika, 2011
Inter-individual variation of cytochrome P4502J2 expression and catalytic activities in liver microsomes from Japanese and Caucasian populations.
Yamazaki H et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 2006
Genetic polymorphisms, drug metabolism and drug concentrations.
Shenfield GM
The Clinical Biochemist. Reviews, 2004